Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
51
Number of overlapping holdings
14.8%
% of FHLC's 369 holdings also in PTH
96.2%
% of PTH's 53 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus PTH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PTH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 4.8% | 4.8% |
|
ABBVIE INC | 5.2% | 2.6% | 2.6% |
|
INTUITIVE SURGICAL INC | 2.5% | 2.6% | 2.5% |
|
REGENERON PHARMACEUTICALS | 1.8% | 2.2% | 1.8% |
|
HCA HOLDINGS INC | 1.1% | 3.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to PTH
|
UNITEDHEALTH GROUP INC | 8.3% |
|
JOHNSON & JOHNSON | 6.1% |
|
ELI LILLY & CO | 5.4% |
|
MERCK & CO. INC. | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
AMGEN INC | 2.8% |
|
PFIZER INC | 2.7% |
|
ABBVIE INC | 2.6% |
FHLC Underweight Relative to PTH
|
VAXCYTE, INC. | -4.4% |
|
INSMED INC | -3.7% |
|
TENET HEALTHCARE CORP | -3.2% |
|
CASSAVA SCIENCES, INC. | -3.0% |
|
NATERA INC | -2.6% |
|
HARROW INC | -2.4% |
|
NURIX THERAPEUTICS, INC. | -2.4% |
|
CATALYST PHARMACEUTICAL PART | -2.4% |
|
DAVITA INC | -2.2% |
|
ADMA BIOLOGICS, INC. | -2.1% |